Clorox Co (CLX) SVP Matthew T. Laszlo Sells 13,485 Shares

Clorox Co (NYSE:CLX) SVP Matthew T. Laszlo sold 13,485 shares of Clorox stock in a transaction on Tuesday, November 20th. The shares were sold at an average price of $161.04, for a total transaction of $2,171,624.40. Following the completion of the transaction, the senior vice president now directly owns 20,098 shares in the company, valued at $3,236,581.92. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

CLX traded up $3.12 during trading on Friday, hitting $162.83. The stock had a trading volume of 390,676 shares, compared to its average volume of 1,187,362. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07. The stock has a market capitalization of $20.39 billion, a P/E ratio of 26.01, a P/E/G ratio of 3.92 and a beta of 0.28. Clorox Co has a twelve month low of $113.57 and a twelve month high of $163.44.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.59 by $0.03. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The company had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the company posted $1.46 EPS. Clorox’s revenue was up 4.2% compared to the same quarter last year. Sell-side analysts predict that Clorox Co will post 6.31 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 8th. Stockholders of record on Wednesday, January 23rd will be paid a dividend of $0.96 per share. The ex-dividend date of this dividend is Tuesday, January 22nd. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.36%. Clorox’s dividend payout ratio (DPR) is presently 61.34%.

Several large investors have recently bought and sold shares of CLX. Morgan Stanley grew its stake in shares of Clorox by 178.2% during the 3rd quarter. Morgan Stanley now owns 3,063,813 shares of the company’s stock worth $460,828,000 after purchasing an additional 1,962,433 shares during the period. Macquarie Group Ltd. grew its stake in shares of Clorox by 437,400.0% during the 2nd quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock worth $236,688,000 after purchasing an additional 1,749,600 shares during the period. Schroder Investment Management Group grew its stake in shares of Clorox by 57.0% during the 2nd quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock worth $201,641,000 after purchasing an additional 547,070 shares during the period. FMR LLC grew its stake in shares of Clorox by 201.0% during the 2nd quarter. FMR LLC now owns 472,179 shares of the company’s stock worth $63,863,000 after purchasing an additional 315,298 shares during the period. Finally, DekaBank Deutsche Girozentrale grew its stake in shares of Clorox by 110.5% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 427,013 shares of the company’s stock worth $61,991,000 after purchasing an additional 224,143 shares during the period. 76.33% of the stock is currently owned by institutional investors and hedge funds.

CLX has been the topic of several recent research reports. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective on the stock in a research note on Wednesday, October 3rd. Argus raised shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 price objective on the stock in a research note on Tuesday, September 25th. ValuEngine raised shares of Clorox from a “hold” rating to a “buy” rating in a research note on Saturday, September 22nd. BMO Capital Markets reissued a “buy” rating and issued a $153.00 price objective on shares of Clorox in a research note on Friday, August 3rd. Finally, Barclays set a $131.00 price objective on shares of Clorox and gave the company a “hold” rating in a research note on Saturday, October 6th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $142.79.

WARNING: This piece was originally published by WKRB News and is owned by of WKRB News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.wkrb13.com/2018/11/24/clorox-co-clx-svp-matthew-t-laszlo-sells-13485-shares.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: Moving Average (MA)

Insider Buying and Selling by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply